Stay updated on Favipiravir Clinical Trial: Influenza Efficacy & Safety
Sign up to get notified when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.

Latest updates to the Favipiravir Clinical Trial: Influenza Efficacy & Safety page
- Check6 days agoChange DetectedThe Sweden location entries were updated to reflect the correct spelling Malmö and two precise site lines: Malmö, Sweden, SE-20502 and Malmö, Skåne County, Sweden, SE-21152. This replaces the previous Malmo entries with standardized naming.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a minor platform release rather than a change to the study information.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.5.2 was added and the previous revision v3.5.0 was removed.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check56 days agoChange DetectedVersion bump from v3.4.2 to v3.4.3; no visible changes to study details or page layout.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing the prior Revision: v3.4.1. This appears to be a site version update that does not alter study content.SummaryDifference0.0%

Stay in the know with updates to Favipiravir Clinical Trial: Influenza Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.